Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in

Markets

Market

News Details

(13/11/2026 14:20)

Natco Pharma Q2 net profit down 71.41% at Rs 143.20 cr

The company reported standalone net profit of Rs 143.20 crore for the quarter ended September 30, 2026 as compared to Rs 500.90 crore in the same period last year, registering a year-on-year decline of 71.41 per cent.

Net revenue of the company declined substantially by 32.41 per cent at Rs 854.50 crore in July-September quarter of this fiscal as against Rs 1,264.30 crore in the corresponding period last year.

During July-September quarter, operating expenses dropped by 10.34 per cent to Rs 638.20 crore from Rs 711.80 crore in year ago period.

Other Income dipped by 56.81 per cent at Rs 40.30 crore versus (Sep'25 Rs 93.30 crore).

Operating Profit slipped by 60.85 per cent to Rs 216.30 crore as against Rs 552.50 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 42.08 per cent in September quarter.

Interest grew by 33.33 per cent y-o-y to Rs 15.60 crore, while Taxation decreased by 36.78 per cent at Rs 53.80 crore (Sep'25 Rs 85.10 crore).